Monocytes may be favorable biomarker and predictor of long-term outcome in patients with chronic heart failure: A cohort study.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
entrez:
1
10
2019
pubmed:
1
10
2019
medline:
11
10
2019
Statut:
ppublish
Résumé
Although some studies found that an increased monocyte count is a predictive, short-term marker of unfavorable outcomes for patients with acute heart failure (HF), others have reported that monocytosis predicts prolonged survival.The current follow-up study aimed to identify different monocyte count patterns and their prognostic association with HF outcomes.Baseline blood samples for complete blood counts, differential counts, renal function tests, and lipid profiles of 303 chronic HF patients (average NYHA classification 2.8) were prospectively obtained to evaluate whether there is an association between monocyte count and clinical outcomes.Mean follow-up was 11.3 years (range 1 month to 16 years) and 111 (36.6%) patients died during follow-up. Mean monocyte count was 10.6 ± 5.5 and mean left ventricular ejection fraction (LVEF) was 36%. Patients with low monocyte counts (≤6%) had significantly lower survival rates than did those with monocyte counts 6.1% to 14%, or >14% (14.3% vs 70.2% vs. 88%, P < .001). Poorest survival was predicted for patients with NYHA class 3 to 4 and monocyte counts ≤6. Regression analysis showed that monocyte levels, NYHA class, and LVEF values were predictors of mortality, in decreasing importance.The total monocyte count was found to be an important prognostic factor that was inversely associated with predicted long-term mortality among patients with chronic HF. A low total monocyte count was strongly correlated with NYHA class and B-type natriuretic peptide levels, but no correlation was found with LVEF and oxidized low-density lipoproteins. It emerged as an independent risk factor for mortality in patients with chronic HF.
Identifiants
pubmed: 31567947
doi: 10.1097/MD.0000000000017108
pii: 00005792-201909200-00017
pmc: PMC6756710
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e17108Références
Naylor S. Biomarkers: current perspectives and future prospects. Expert Rev Mol Diagn 2003;3:525–9.
Shahid F, Lip GYH, Shantsila E. Role of monocytes in heart failure and atrial fibrillation. J Am Heart Assoc 2018;7:e007849.
Wong KL, Yeap WH, Tai JJ, et al. The three human monocyte subsets: implications for health and disease. Immunol Res 2012;53:41–57.
Wrigley BJ, Shantsila E, Tapp LD, et al. CD14++CD16+ monocytes in patients with acute ischaemic heart failure. Eur J Clin Invest 2013;43:121–30.
Apostolakis S, Lip GY, Shantsila E. Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair? Cardiovasc Res 2010;85:649–60.
Wrigley BJ, Shantsila E, Tapp LD, et al. Increased formation of monocyte-platelet aggregates in ischemic heart failure. Circ Heart Fail 2013;6:127–35.
Prentice RL, Szatrowski TP, Fujikura T, et al. Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Epidemiol 1982;116:496–509.
Umemoto S, Suzuki N, Fujii K, et al. Eosinophil counts and plasma fibrinogen in patients with vasospastic angina pectoris. Am J Cardiol 2000;85:715–9.
Olivares R, Ducimetiere P, Claude JR. Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol 1993;137:49–53.
Yun KH, Oh SK, Park EM, et al. An increased monocyte count predicts coronary artery spasm in patients with resting chest pain and insignificant coronary artery stenosis. Korean J Intern Med 2006;21:97–102.
Afiune Neto A, Mansur Ade P, Avakian SD, et al. Monocytosis is an independent risk marker for coronary artery disease [in Portuguese]. Arq Bras Cardiol 2006;86:240–4.
Wheeler JG, Mussolino ME, Gillum RF, et al. Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals. Eur Heart J 2004;25:1287–92.
Avanzas P, Quiles J, Lopez de Sa E, et al. Neutrophil count and infarct size in patients with acute myocardial infarction. Int J Cardiol 2004;97:155–6.
Madjid M, Fatemi O. Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update. Tex Heart Inst J 2013;40:17–29.
Zawada AM, Rogacev KS, Rotter B, et al. SuperSAGE evidence for CD14++CD16+monocytes as a third monocyte subset. Blood 2011;118:e50–61.
Shantsila E, Wrigley B, Tapp L, et al. Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology. J Thromb Haemost 2011;9:1056–66.
Wrigley BJ, Lip GY, Shantsila E. The role of monocytes and inflammation in the pathophysiology of heart failure. Eur J Heart Fail 2011;13:1161–71.
Grau AJ, Boddy AW, Dukovic DA, et al. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 2004;35:1147–52.
Sweetnam PM, Thomas HF, Yarnell JW, et al. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. Am J Epidemiol 1997;145:416–21.
Avanzas P, Arroyo-Espliguero R, Cosin-Sales J, et al. Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart 2004;90:847–52.
Van Craenenbroeck AH, Van Ackeren K, Hoymans VY, et al. Acute exercise-induced response of monocyte subtypes in chronic heart and renal failure. Mediators Inflamm 2014;216534doi: 10.1155/2014/216534.
doi: 10.1155/2014/216534
Kawaguchi H, Mori T, Kawano T, et al. Band neutrophil count and the presence and severity of coronary atherosclerosis. Am Heart J 1996;132:9–12.
Biasucci LM, D’Onofrio G, Liuzzo G, et al. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol 1996;27:611–6.
Gillum RF, Mussolino ME, Madans JH. Counts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: the NHANES-I epidemiologic follow-up study. Ann Epidemiol 2005;15:266–71.
Thompson S, McMahon L, Nugent C. Endogenous cortisol a regulator of the number of lymphocytes in peripheral blood. Clin Immunol Immunopathol 1980;17:506–14.
Acanfora D, Gheorghiade M, Trojano L, et al. Relative lymphocyte count; a prognostic indicator of mortality in elderly patients with congestive heart failure. Am Heart J 2001;142:167–73.
Shimoni S, Meledin V, Bar I, et al. Circulating CD14(+) monocytes in patients with aortic stenosis. J Geriatr Cardiol 2016;13:81–7.
Akiyama Y, Miller PJ, Thurman GB, et al. Stevenson HC characterization of a human blood monocyte subset with low peroxidase activity. J Clin Invest 1983;72:1093–105.
Tallone T, Turconi G, Soldati G, et al. Heterogeneity of human monocytes: an optimized four-color flow cytometry protocol for analysis of monocyte subsets. J Cardiovasc Transl Res 2011;4:211–9.
Li Zhu, Yigang Yin, Ruifang Zhou, et al. Changes of monocyte subsets in patients with acute coronary syndrome and correlation with myocardial injury markers. Int J Clin Exp Pathol 2015;8:7266–71.
Figdor CG, Bont WS, Touw I, et al. Isolation of functionally different human monocytes by counter flow centrifugation elutriation. Blood 1982;60:46–53.
Berg KE, Ljungcrantz I, Andersson L, et al. Elevated CD14++CD16+ Monocytes Predict Cardiovascular Events. Circ Cardiovasc Genet 2012;5:122–31.
Hristov M, Weber C. Differential role of monocyte subsets in atherosclerosis. Thromb Haemost 2011;106:757–62.
Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 2010;10:427–39.
Wrigley BJ, Shantsila E, Tapp LD. Increased formation of monocyte-platelet aggregates in ischemic heart failure. Circ Heart Fail 2013;6:127–35.
van der Laan AM, Hirsch A, Robbers LF, et al. A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarction. Am Heart J 2012;163:57–65.e2.
Wilcox RA, Ristow K, Habermann TM, et al. The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma. Leuk Lymphoma 2012;53:575–80.
Naert G, Rivest S. A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease. J Molecular Cell Biol 2013;5:284–93.
Bao Y, Eunhee Kim E, Sangram Bhosle S, et al. A role for spleen monocytes in post-ischemic brain inflammation and injury. J Neuroinflamm 2010;7:92–5.
De Rosa S, Eposito F, Carella C, et al. Transcoronary concentration gradients of circulating microRNAs in heart failure. Eur J Heart Fail 2018;20:1000–10.